Sartorius Aktiengesellschaft (ETR:SRT3)
239.60
-2.20 (-0.91%)
At close: Feb 6, 2026
ETR:SRT3 Revenue
Sartorius Aktiengesellschaft had revenue of 843.20M EUR in the quarter ending September 30, 2025, with 6.25% growth. This brings the company's revenue in the last twelve months to 3.52B, up 5.82% year-over-year. In the year 2024, Sartorius Aktiengesellschaft had annual revenue of 3.38B, down -0.44%.
Revenue (ttm)
3.52B
Revenue Growth
+5.82%
P/S Ratio
4.19
Revenue / Employee
253.44K
Employees
13,878
Market Cap
14.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.38B | -15.00M | -0.44% |
| Dec 31, 2023 | 3.40B | -779.00M | -18.66% |
| Dec 31, 2022 | 4.17B | 725.50M | 21.03% |
| Dec 31, 2021 | 3.45B | 1.11B | 47.68% |
| Dec 31, 2020 | 2.34B | 508.69M | 27.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.23B |
Sartorius Aktiengesellschaft News
- 4 days ago - Sartorius Aktiengesellschaft 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 5 days ago - Sartorius AG (SUVPF) (Q4 2025) Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 5 days ago - Sartorius Aktiengesellschaft (SOAGY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Preliminary Q4 2025 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript - GuruFocus
- 5 days ago - Sartorius Group Preliminary FY25 Profit Rises - Nasdaq
- 5 days ago - Sartorius Aktiengesellschaft Non-GAAP EPS of €4.78, revenue of €3.54B; initiates FY26 outlook - Seeking Alpha
- 25 days ago - EQS-News: Sartorius expands bio-circular product offering for more sustainable bioprocesses - Wallstreet:Online
- 7 weeks ago - EQS-AFR: Sartorius AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - Wallstreet:Online